Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 79


A case of isolated adrenocorticotropic hormone deficiency: a rare but possible cause of hypercalcemia.

Harano Y, Kitano A, Akiyama Y, Kotajima L, Honda K, Arioka H.

Int Med Case Rep J. 2015 Mar 27;8:77-9. doi: 10.2147/IMCRJ.S63778. eCollection 2015.


A Case of IgG4-Related Hypophysitis Presented with Hypopituitarism and Diabetes Insipidus.

Harano Y, Honda K, Akiyama Y, Kotajima L, Arioka H.

Clin Med Insights Case Rep. 2015 Mar 12;8:23-6. doi: 10.4137/CCRep.S15352. eCollection 2015.


Case of cytomegalovirus colitis in an immunocompetent patient: a rare cause of abdominal pain and diarrhea in the elderly.

Harano Y, Kotajima L, Arioka H.

Int J Gen Med. 2015 Mar 3;8:97-100. doi: 10.2147/IJGM.S63771. eCollection 2015.


A predictive rule for mortality of inpatients with Staphylococcus aureus bacteraemia: A classification and regression tree analysis.

Kobayashi D, Yokota K, Takahashi O, Arioka H, Fukui T.

Eur J Intern Med. 2014 Dec;25(10):914-8. doi: 10.1016/j.ejim.2014.10.003. Epub 2014 Oct 14.


Variability in measuring the Ki-67 labeling index in patients with breast cancer.

Yamamoto S, Chishima T, Mastubara Y, Adachi S, Harada F, Toda Y, Arioka H, Hasegawa N, Kakuta Y, Sakamaki K.

Clin Breast Cancer. 2015 Feb;15(1):e35-9. doi: 10.1016/j.clbc.2014.09.005. Epub 2014 Oct 22.


Serum p53 antibody in breast cancer.

Yamamoto S, Chishima T, Adachi S, Harada F, Toda Y, Arioka H, Hasegawa N, Kakuta Y.

Cancer Biomark. 2014;14(4):203-6. doi: 10.3233/CBM-140396.


Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma.

Ikeda M, Shiina S, Nakachi K, Mitsunaga S, Shimizu S, Kojima Y, Ueno H, Morizane C, Kondo S, Sakamoto Y, Asaoka Y, Tateishi R, Koike K, Arioka H, Okusaka T.

Invest New Drugs. 2014 Oct;32(5):928-36. doi: 10.1007/s10637-014-0109-2. Epub 2014 May 15.


[Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer].

Soda H, Nemoto H, Akatsuka S, Arioka H, Shimada K, Ito T, Takinishi Y, Egawa M, Nagashima A, Kenmochi T, Sasaki T, Azuma T, Koizumi W, Hibi K.

Gan To Kagaku Ryoho. 2013 May;40(5):605-8. Japanese.


A randomised phase II study of TSU-68 in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.

Inaba Y, Kanai F, Aramaki T, Yamamoto T, Tanaka T, Yamakado K, Kaneko S, Kudo M, Imanaka K, Kora S, Nishida N, Kawai N, Seki H, Matsui O, Arioka H, Arai Y.

Eur J Cancer. 2013 Sep;49(13):2832-40. doi: 10.1016/j.ejca.2013.05.011. Epub 2013 Jun 10.


A prediction rule for the development of delirium among patients in medical wards: Chi-Square Automatic Interaction Detector (CHAID) decision tree analysis model.

Kobayashi D, Takahashi O, Arioka H, Koga S, Fukui T.

Am J Geriatr Psychiatry. 2013 Oct;21(10):957-62. doi: 10.1016/j.jagp.2012.08.009. Epub 2013 Feb 6.


Risk factors for adverse reactions from contrast agents for computed tomography.

Kobayashi D, Takahashi O, Ueda T, Deshpande GA, Arioka H, Fukui T.

BMC Med Inform Decis Mak. 2013 Jan 30;13:18. doi: 10.1186/1472-6947-13-18.


Breast cancer manifested by hematologic disorders.

Ishikawa T, Shimizu D, Kito A, Ota I, Sasaki T, Tanabe M, Yamada A, Arioka H, Shimizu S, Wakasugi J, Mori R, Chishima T, Ichikawa Y, Endo I.

J Thorac Dis. 2012 Dec;4(6):650-4. doi: 10.3978/j.issn.2072-1439.2012.10.17.


[Skin toxicity, alopecia].

Katsura Y, Akatsuka S, Toda Y, Arioka H.

Nihon Rinsho. 2012 Aug;70 Suppl 6:166-71. Japanese. No abstract available.


The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan.

Kobayashi D, Takahashi O, Arioka H, Fukui T.

BMC Gastroenterol. 2012 Oct 17;12:144. doi: 10.1186/1471-230X-12-144.


A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane.

Suzuki Y, Saeki T, Aogi K, Toi M, Fujii H, Inoue K, Watanabe T, Fujiwara Y, Ito Y, Takatsuka Y, Iwata H, Arioka H, Tokuda Y.

Int J Clin Oncol. 2013 Aug;18(4):590-7. doi: 10.1007/s10147-012-0421-9. Epub 2012 May 15.


Asthma severity is a risk factor for acute hypersensitivity reactions to contrast agents: a large-scale cohort study.

Kobayashi D, Takahashi O, Ueda T, Arioka H, Akaishi Y, Fukui T.

Chest. 2012 May;141(5):1367-8. doi: 10.1378/chest.11-3143. No abstract available.


A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.

Toi M, Saeki T, Iwata H, Inoue K, Tokuda Y, Sato Y, Ito Y, Aogi K, Takatsuka Y, Arioka H.

Breast Cancer. 2014 Jan;21(1):20-7. doi: 10.1007/s12282-012-0344-3. Epub 2012 Mar 2.


High sleep duration variability is an independent risk factor for weight gain.

Kobayashi D, Takahashi O, Shimbo T, Okubo T, Arioka H, Fukui T.

Sleep Breath. 2013 Mar;17(1):167-72. doi: 10.1007/s11325-012-0665-7. Epub 2012 Feb 22.


Behavior of Adult Influenza Patients during the 2009 Pandemic after Outpatient Clinic Presentations at a Hospital in Tokyo, Japan.

Nonaka D, Morikawa H, Arioka H, Kobayashi J, Shoda R, Mizoue T.

Trop Med Health. 2011 Sep;39(3):83-5. doi: 10.2149/tmh.2011-09. Epub 2011 Sep 30.


An early intensive intervention for inducing inactive asthma in adults--a one-year follow-up observation study.

Kudo K, Arioka H, Takeda Y, Shimbo T, Handa S, Kawana A, Kamimura M, Yamauchi Y, Nagase H, Kobayashi N, Manabe T, Kabe J.

Allergol Int. 2011 Dec;60(4):433-41. doi: 10.2332/allergolint.10-OA-0280. Epub 2011 May 25.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk